Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-26 @ 2:00 AM
Study NCT ID:
NCT00813605
Status:
COMPLETED
Last Update Posted:
2016-10-27
First Post:
2008-12-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
QUILT-2.018: Safety & Efficacy of FOLFIRI With AMG 479 or AMG 655 vs FOLFIRI Alone in KRAS-mutant Metastatic Colorectal Carcinoma
Sponsor:
NantCell, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Colorectal Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | AMG 655 | View |
| None | AMG 479 | View |
| None | Colon Cancer | View |
| None | Rectal Cancer | View |
| None | Monoclonal Antibody | View |
| None | Clinical Trial | View |
| None | Colorectal Cancer | View |
| None | metastatic colorectal cancer | View |
| None | metastatic cancer | View |
| None | antibody-2nd line | View |
| None | KRAS | View |
| None | adenocarcinoma | View |